VN

Valery Novokhatny

GT Grifols Therapeutics: 7 patents #1 of 47Top 3%
TB Talecris Biotherapeutics: 3 patents #1 of 26Top 4%
BH Bayer Healthcare: 1 patents #4,623 of 8,007Top 60%
GS Grifols, S.A.: 1 patents #30 of 81Top 40%
📍 Raleigh, NC: #686 of 6,378 inventorsTop 15%
🗺 North Carolina: #4,231 of 45,564 inventorsTop 10%
Overall (All Time): #416,121 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
9879246 Reversibly inactivated acidified plasmin composition Thomas P. Zimmerman, Shan Jiang, James Colandene 2018-01-30
9028465 Therapeutic delivery devices, systems, and methods Dean Chamberlain, David Fineberg 2015-05-12
8512980 Recombinantly modified plasmin 2013-08-20
8420079 Recombinantly modified plasmin Jennifer Hunt 2013-04-16
8231869 Recombinant plasmin for opthalmic indications Philip Scuderi, Vikram Arora, Jennifer Hunt, Stephen Robert Petteway 2012-07-31
8182808 Recombinantly modified plasmin 2012-05-22
8101394 Recombinantly modified plasmin 2012-01-24
8034913 Recombinantly modified plasmin Jennifer Hunt 2011-10-11
7871608 Reversibly inactivated acidified plasmin Thomas P. Zimmerman, Shan Jiang, James Colandene 2011-01-18
7544500 Process for the production of a reversibly inactive acidified plasmin composition Rita T. Bradley, Scott A. Cook, Christopher A. Dadd, Jonathan D. Kent, Marina Korneyeva +5 more 2009-06-09
6964764 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin Thomas P. Zimmerman, Kyle Landskroner, Gary Jesmok, Kathryn K. Taylor 2005-11-15
6355243 Method of thrombolysis by local delivery of active plasmin Gary Jesmok, Kyle Landskroner, Kathryn K. Taylor, Thomas P. Zimmerman 2002-03-12